Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jiten Morarji"'
Publikováno v:
Case Reports in Ophthalmology, Vol 3, Iss 3, Pp 286-290 (2012)
We report a patient with necrotising scleritis in whom infliximab was used for short-term steroid-sparing while rituximab took effect. This enabled disease control without requiring an extended period of high-dose corticosteroid administration or the
Externí odkaz:
https://doaj.org/article/ab0e72c367234fb58180a2b9f09b681d
Publikováno v:
Case Reports in Ophthalmology, Vol 3, Iss 3, Pp 283-285 (2012)
We present the first reported case of acute endophthalmitis due to Rhizobium radiobacter after an intravitreal injection of ranibizumab for neovascular age-related macular degeneration.
Externí odkaz:
https://doaj.org/article/db81d87bf95a4abbaa91ca6d38b7fa01
Autor:
Peter J Morgan-Warren, Jiten Morarji
Publikováno v:
Eye
Objectives The grant of marketing authorisation (MA) for new medicines requires comprehensive assessment by regulatory authorities. This study sought to identify ophthalmic medicines granted United Kingdom MA and consider trends in licence approvals.
Publikováno v:
JOURNAL OF CATARACT AND REFRACTIVE SURGERY
Purpose To define the incidence of cystoid macular edema (CME) and spectral-domain optical coherence tomography–detectable (SD-OCT) subclinical changes in central retinal thickness in patients using prostaglandin analog (PGA) eyedrops after phacoem
Autor:
Stephen Taylor, Panayiotis Vouzounis, Satish Yaganti, Oren Tomkins-Netzer, Lavnish Joshi, Asaf Bar, Susan Lightman, Sophie Seguin-Greenstein, Jiten Morarji
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Background Outcomes of intravitreal antivascular endothelial growth factor injections are variable among patients with diabetic macular edema (DME). The aim of this study was to determine the ocular and systemic predictors of DME response to intravit
Autor:
Rachel L. Taylor, Elisabeth J. Nichol, Sofia Douzgou, Graeme C.M. Black, Georgina Hall, Jill Clayton-Smith, Jiten Morarji, Claire Hardcastle, Jamie M Ellingford, Susmito Biswas, Stephanie Barton, Vinod Sharma, Simon C Ramsden, I Chris Lloyd, Claire M. Delaney, Lindsi C. Williams, Jane Ashworth, Panagiotis I. Sergouniotis, Christopher Campbell, Neil R. A. Parry
Publikováno v:
Ophthalmology. 124(7)
Purpose To assess the clinical usefulness of genetic testing in a pediatric population with inherited retinal disease (IRD). Design Single-center retrospective case series. Participants Eighty-five unrelated children with a diagnosis of isolated or s
Publikováno v:
Case Reports in Ophthalmology, Vol 3, Iss 3, Pp 286-290 (2012)
Case Reports in Ophthalmology
Case Reports in Ophthalmology
We report a patient with necrotising scleritis in whom infliximab was used for short-term steroid-sparing while rituximab took effect. This enabled disease control without requiring an extended period of high-dose corticosteroid administration or the
Publikováno v:
Morarji, J, Lenassi, E, Black, G C M & Ashworth, J L 2016, ' Atypical presentation of CRB1 retinopathy ', Acta Ophthalmologica, vol. 94, no. 6, pp. e513-e514 . https://doi.org/10.1111/aos.12997
Autor:
Carmel Toomes, Gavin Arno, Anthony T. Moore, Martin McKibbin, Andrew R. Webster, Manir Ali, Nikolas Pontikos, Katherine R. Smith, Jill Clayton-Smith, James A. Poulter, Jiten Morarji, Alison J. Hardcastle, Rachel L. Taylor, Chris F. Inglehearn, Michel Michaelides, Graeme C.M. Black, Sarah Hull, Stephanie Grunewald, Antonio Rueda Martin, Kamron N. Khan
Publikováno v:
JAMA Ophthalmology. 135:339
Importance: Steroid 5α-reductase type 3 congenital disorder of glycosylation (SRD5A3-CDG) is a rare disorder of N-linked glycosylation. Its retinal phenotype is not well described but could be important for disease recognition because it appears to
Autor:
Rita Horvath, Jiten Morarji, Graeme C.M. Black, Panagiotis I. Sergouniotis, Rachel L. Gillespie
Publikováno v:
JAMA Ophthalmology. 135:167